India's Intas Pharma Said Reconsidering IPO Launch
This article was originally published in PharmAsia News
Executive Summary
Intas Pharmaceutical reportedly is considering cancellation of its plan to launch an initial public offering during a year in which IPO values in India fell to a decade low.